Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.44 | 37.05 |
| PEG Ratio (TTM) | 0.93 | 11.98 |
| P/S Ratio (TTM) | 1.62 | 14.61 |
| P/B Ratio (TTM) | 1.33 | 18.78 |
| P/FCF Ratio (TTM) | -4.19 | 42.97 |
| Price to 5YR AVG Earnings Ratio | 11.96 | 32.96 |
| Price to 5YR AVG FCF Ratio | 66.89 | 63.36 |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.66% | 12.20% |
| ROE (TTM) | 13.11% | -7.48% |
| Net Profit Margin (TTM) | 15.96% | 24.97% |
| ROIC 5YR AVG | 8.78% | 4.50% |
Growth (72%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 21.16% | -28.61% | 75.49% |
| Revenue | 2.95% | 44.41% | 51.25% |
| Net Income | 20.87% | -30.52% | 74.53% |
| Cash Flow | -317.94% | 2,126.02% | 1,264.52% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.36 | 1.43 |
| Quick Ratio (TTM) | 1.36 | 1.41 |
| D/E Ratio (TTM) | 0.45 | 1.24 |
| Interest Coverage (TTM) | 0.59 | 35.48 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 0.78 | 9.32 |
| LTL to 5YR AVG FCF | 68.37 | 5.27 |
| Shares Outstanding Growth 5YR AVG | 2.47% | 0.66% |